Michael Brooks
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Michael Brooks currently works at Edesa Biotech, Inc., as President from 2019.
Dr. Brooks also formerly worked at Cipher Pharmaceuticals, Inc., as Director-Business Development from 2010 to 2015, Edesa Biotech, Inc. (Old), as President, and Edesa Biotech Research, Inc., as Vice President-Corporate Development & Strategy.
Dr. Brooks received his Masters Business Admin degree from Rotman School of Management and undergraduate degree and doctorate degree from the University of Toronto.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EDESA BIOTECH, INC. 3,28% | 27-05-2026 | 291.479 ( 3,28% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EDESA BIOTECH, INC. | President | 07-06-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 01-01-2015 |
Edesa Biotech Research, Inc. | Corporate Officer/Principal | - |
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Develops novel non-steroidal molecules for the treatment of allergic contact dermatitis | President | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Cipher Pharmaceuticals, Inc.
Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Rotman School of Management
Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Develops novel non-steroidal molecules for the treatment of allergic contact dermatitis | Health Technology |
Edesa Biotech, Inc.
Edesa Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of chronic allergic contact dermatitis | Health Technology |
Edesa Biotech Research, Inc. |
Kies jouw editie
Alle financiële informatie op nationaal niveau